Santa Cruz Biotechnology Opens New Office in Canada

The new location will provide better support for Canadian customers

Mississauga, Ontario

Santa Cruz Biotechnology, Inc., a world leader in the development of products for the biomedical research market, announces expansion to a new sales office opening near Toronto, Canada to accommodate their rapid growth and future expansion plans. The 20,000 square foot facility located in Mississauga, Canada, will provide capacity for continued growth and meet demands for new monoclonal antibodies and research products. Mississauga boasts a population rich in diversity, culture and history. Now being Canada’s 6th largest city, Mississauga is an important hub for industry and commerce, and serves as headquarters to 60 of the world’s Fortune 500 companies.

Founders John and Brenda Stephenson are excited about the expansion into Canada. “Santa Cruz Biotechnology, Inc.’s new office space will allow us to increase capabilities that align with our current and future growth plans. The new space will allo

< | >